Lee Ainslie Wave Life Sciences Ltd. Transaction History
Maverick Capital LTD
- $5.17 Billion
- Q4 2024
A detailed history of Lee Ainslie (Maverick Capital LTD) transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Maverick Capital LTD holds 8,261,242 shares of WVE stock, worth $86.6 Million. This represents 1.98% of its overall portfolio holdings.
Number of Shares
8,261,242
Previous 10,047,520
17.78%
Holding current value
$86.6 Million
Previous $82.4 Million
24.03%
% of portfolio
1.98%
Previous 1.71%
Shares
13 transactions
Others Institutions Holding WVE
# of Institutions
191Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$191 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$101 Million0.22% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$70.6 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$70.3 Million0.81% of portfolio
-
M28 Capital Management LP Stamford, CT5.66MShares$59.4 Million56.95% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $910M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...